Results from the COAPT study continue to roll in, and it was all positive news for the MitraClip team at the TCT conference in San Francisco this month.

A shortened, three-month course of dual antiplatelet therapy might be a safer bet than 12-month treatment for patients at a high risk of bleeding after PCI and implantation of a drug-eluting stent.

Research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this month suggests having high blood pressure speeds up cognitive decline in middle-aged and older adults—but treating the condition can reverse that possibility.

CRF program planners describe how they’re building on last year’s momentum with even more practical programming.

Nearly two-thirds of American medical students have higher-than-average blood pressure, according to research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Native Hawaiians who struggled to control their high blood pressure and type 2 diabetes benefited greatly from a six-month hula dancing program, researchers reported at the American Heart Association’s Hypertension 2019 Scientific Sessions.

Preliminary research presented at the American Heart Association’s Hypertension 2019 Scientific Sessions this week suggests gut bacteria could be an indicator of whether someone with high blood pressure also suffers from depression.

More than 30% of Danish heart patients with an ICD resume driving during a “banned period” following their index procedure, researchers reported at the ESC Congress in Paris on Sept. 3.

Research presented at the ESC Congress in Paris Sept. 2 suggests malaria could be linked to as much as a 30% increased risk of heart failure.

Young people who used their smartphone five or more hours per day were 43% more likely to be obese than their counterparts with less reported screen time in a recent study presented at the ACC Latin American Conference 2019 in Cartagena, Colombia.

The Cardiovascular Research Foundation is partnering with VEITHsymposium, one of the largest annual meetings in vascular medicine, to enhance conference material at both VEITHsymposium and the CRF’s yearly Transcatheter Cardiovascular Therapeutics conference, the groups announced June 20.

A novel robotic catheter could simplify valve procedures while allowing cardiac surgeons to complete multiple interventions within the same time frame, according to research presented at TVT 2019 in Chicago.